TCM

TCG Crossover Management Portfolio holdings

AUM $876M
1-Year Est. Return 23.66%
This Quarter Est. Return
1 Year Est. Return
+23.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.18B
AUM Growth
+$221M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1 +$48.8M
2 +$32.7M
3 +$18.7M
4
MBX
MBX Biosciences
MBX
+$16.9M
5
GPCR icon
Structure Therapeutics
GPCR
+$16.2M

Top Sells

1 +$41.8M
2 +$10.7M
3 +$8.66M
4
CCCC icon
C4 Therapeutics
CCCC
+$5.9M
5
SLN
Silence Therapeutics
SLN
+$4.76M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
26
$9.35M 0.79%
584,955
27
$8.06M 0.68%
2,676,580
28
$7.62M 0.65%
231,820
-324,497
29
$7.37M 0.62%
922,335
30
$5.2M 0.44%
266,667
31
$4.68M 0.4%
64,023
32
$4.59M 0.39%
+483,000
33
$2.63M 0.22%
1,008,158
+108,159
34
$1.66M 0.14%
1,555,118
35
$689K 0.06%
316,195
36
$410K 0.03%
86,795
37
-1,276,574
38
-149,283